Business
AsymBio Completes its Dual-Site, One-Center Network with Fengxian Commercial Manufacturing Site Operational, Enhancing End-to-End Biologics CDMO Capabilities
SHANGHAI, March 09, 2026 (GLOBE NEWSWIRE) -- AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ /6821.HK), recently announced that its Fengxian commercial manufacturing site in Shanghai has officially commenced operations. This milestone completes a Shanghai-based “Golden Triangle” footprint comprising the Zhangjiang Science & Technology Center, Jinshan Site, and Fengxian Site. The three locations integrate end-to-end CDMO capabilities from early R&D and process development through c
About this update from Asymchem Laboratories (tianjin) Co., Ltd. Class A
[{"type":"image","alt":"AsymBio","displaySize":"","headline":null,"caption":"AsymBio","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":162,"url":"https://media.zenfs.com/en/globenewswire.com/ee90dad39332b571dc3eb7ace70458ef"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ogJV_Ucpcua.nzhspX6gZA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ee90dad39332b571dc3eb7ace70458ef","width":300,"height":162}},"lazy":false},{"type":"text","content":"SHANGHAI, March 09, 2026 (GLOBE NEWSWIRE) -- AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ /6821.HK), recently announced that its Fengxian commercial manufacturing site in Shanghai has officially commenced operations. This milestone completes a Shanghai-based “Golden Triangle” footprint comprising the Zhangjiang Science & Technology Center, Jinshan Site, and Fengxian Site. The three locations integrate end-to-end CDMO capabilities from early R&D and process development through clinical pilot-scale production, to commercial manufacturing, advancing client programs from IND to BLA through efficient cross-site coordination.","length":658,"tagName":"p"},{"type":"text","content":"AsymBio’s “Dual Sites + One Center” model provides connected functions and complementary strengths across the biologics lifecycle:","length":130,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Zhangjiang Science & Technology Center: A technology-driven central engine for innovation, focusing on early R&D and process development for antibodies, proteins, novel drug conjugates (NDCs), and other advanced therapies, with forward-looking technology deployment. The Center builds and optimizes technology platforms for cell line development, upstream/downstream process development and optimization, conjugation toolbox development, and analytical method development. It supports concept-to-process translation and enables defined technology transfer pathways for subsequent pilot and commercial manufacturing.","length":623,"tagName":"p"}]},{"val":[{"type":"text","content":"Jinshan Site: A one-stop manufacturing site providing manufacturing services from clinical supply and pilot-scale to commercial production, covering drug substance (DS) and drug product (DP) capabilities for antibodies, protein therapeutics, A...
More updates from Asymchem Laboratories (tianjin) Co., Ltd. Class A